Insights from 2025 ASCO® GI Annual Meeting
Video Player is loading.
10 seconds
Playback speed
ASCO® GI 2025 Summary: Evaluating the Clinical Benefits of Anti-Cancer Drugs Approved by FDA for GI Neoplasms for the Past Two Decades
By
Insights from 2025 ASCO® GI Annual Meeting
FEATURING
Fares Jamal
By
Insights from 2025 ASCO® GI Annual Meeting
FEATURING
Fares Jamal
Comments 0
Login to view comments.
Click here to Login
